Top Markets
#1 Bitway Bitway +50.82%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +41.43%
#3 Pons Pons +36.47%
#4 Starpower Starpower +29.47%
#5 Mubarak Mubarak +28.46%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.98%
#7 Ocean Protocol Ocean Protocol +22.74%
#8 StonkBroker StonkBroker +21.51%
#9 SkyAI SkyAI +20.24%
#10 PondCoin PondCoin +18.22%
Coin of the day
Bitway Bitway
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd

SynCore Biotechnology Co.,Ltd

4192
Classifica tra le azioni #29318
SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the... SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the development and commercialization of biotechnology services, alongside offering expertise in food advisory and medicine inspection. The company's robust pipeline includes several promising drug candidates. Among its novel chemical entities (NCEs), SB01 is an injectable anti-cancer compound currently undergoing Phase II clinical trials for head and neck cancer. Another anti-cancer NCE, SB02, is in preclinical development, targeting stomach cancer. Beyond novel compounds, SynCore also markets established pharmaceutical solutions. This includes SB03-Veregen, an ointment prescribed for external genital and perianal warts. Its portfolio further extends to SB04, a conventional medication for age-related macular degeneration, presently in Phase II clinical studies. Additionally, SynCore is advancing SB05-EndoTAG, an established drug undergoing Phase III clinical trials for the treatment of both pancreatic cancer and triple-negative breast cancer. In a related venture, the company distributes epiCam brand cameras, which are designed for recording the progression of ophthalmic diseases. SynCore maintains strategic collaborations with notable entities such as Medigene AG, MacuCLEAR Inc., Sinphar Pharmaceutical Co., Ltd., and The National Health Research Institutes. Founded in 2008, SynCore Biotechnology Co.,Ltd is headquartered in Yilan City, Taiwan, and operates as a subsidiary of Sinphar Pharmaceutical Co., Ltd.
Prezzo delle azioni
$0.62008105
Ultima sincronizzazione: 2026-08-18
Capitalizzazione di mercato
$21.81M
Variazione (1 giorno)
0.26%
Variazione (1 anno)
-31.95%
Paese
TW
Scambia SynCore Biotechnology Co.,Ltd (4192)

Categoria

Healthcare
Il prezzo 4192 con la capitalizzazione del mercato della B
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd
4192
$0.62008105
Capitalizzazione di mercato di SynCore Biotechnology Co.,Ltd(4192)
Capitalizzazione di mercato: $21.81M
A partire dal August 2026, SynCore Biotechnology Co.,Ltd ha una capitalizzazione di mercato pari a $21.81M. Questo rende SynCore Biotechnology Co.,Ltd la 29318th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di SynCore Biotechnology Co.,Ltd dal 2013 al 2026
4192 in paragone con la classifica dei più popolari stocks
Il prezzo per 4192 Attivo B Capitalizzazione del mercato a B Risultati
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd
$150,981 $21.81M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.309T +24,348,474.24%
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd
$132,326 $21.81M
Apple Inc. Apple Inc.
AAPL
$4.653T +21,340,034.07%
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd
$117,642 $21.81M
Alphabet Inc. Alphabet Inc.
GOOG
$4.137T +18,971,961.35%
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd
$101,878 $21.81M
Microsoft Corporation Microsoft Corporation
MSFT
$3.583T +16,429,646.46%
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd
$80,419.00 $21.81M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.828T +12,969,010.62%